{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:54:27Z","timestamp":1791161667265,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.neuroscience.2008.12.026","type":"journal-article","created":{"date-parts":[[2008,12,25]],"date-time":"2008-12-25T10:22:55Z","timestamp":1230200575000},"page":"16-20","source":"Crossref","is-referenced-by-count":22,"title":["Comparison of intrastriatal administration of noradrenaline and l-DOPA on dyskinetic movements: A bilateral reverse in vivo microdialysis study in 6-hydroxydopamine-lesioned rats"],"prefix":"10.1016","volume":"159","author":[{"given":"K.","family":"Buck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ferger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuroscience.2008.12.026_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neulet.2005.10.069","article-title":"alpha2-Adrenoceptor-mediated modulation of the release of GABA and noradrenaline in the rat substantia nigra pars reticulata","volume":"395","author":"Alachkar","year":"2006","journal-title":"Neurosci Lett"},{"issue":"8","key":"10.1016\/j.neuroscience.2008.12.026_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/mds.20612","article-title":"Nondopaminergic mechanisms in levodopa-induced dyskinesia","volume":"20","author":"Brotchie","year":"2005","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neuroscience.2008.12.026_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nbd.2007.08.010","article-title":"Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats","volume":"29","author":"Buck","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.neuroscience.2008.12.026_bib4","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/j.1471-4159.2006.03696.x","article-title":"Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats","volume":"96","author":"Carta","year":"2006","journal-title":"J Neurochem"},{"issue":"6","key":"10.1016\/j.neuroscience.2008.12.026_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00002826-200311000-00008","article-title":"Noradrenergic drugs for levodopa-induced dyskinesia","volume":"26","author":"Colosimo","year":"2003","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"10.1016\/j.neuroscience.2008.12.026_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2007.01.013","article-title":"Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model","volume":"179","author":"Dekundy","year":"2007","journal-title":"Behav Brain Res"},{"issue":"22","key":"10.1016\/j.neuroscience.2008.12.026_bib7","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.2174\/092986707781745550","article-title":"Noradrenaline in Parkinson's disease: from disease progression to current therapeutics","volume":"14","author":"Fornai","year":"2007","journal-title":"Curr Med Chem"},{"issue":"4","key":"10.1016\/j.neuroscience.2008.12.026_bib8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/mds.1148","article-title":"Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan","volume":"16","author":"Fox","year":"2001","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.neuroscience.2008.12.026_bib9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00002826-199310000-00004","article-title":"Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys","volume":"16","author":"Gomez-Mancilla","year":"1993","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"10.1016\/j.neuroscience.2008.12.026_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002109900167","article-title":"Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys","volume":"361","author":"Grondin","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"10.1016\/j.neuroscience.2008.12.026_bib11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1531-8257(199909)14:5<744::AID-MDS1006>3.0.CO;2-7","article-title":"The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease","volume":"14","author":"Henry","year":"1999","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.neuroscience.2008.12.026_bib12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0306-4522(99)00260-2","article-title":"Adrenergic alpha2C-receptors reside in rat striatal GABAergic projection neurons: comparison of radioligand binding and immunohistochemistry","volume":"93","author":"Holmberg","year":"1999","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuroscience.2008.12.026_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuint.2006.08.004","article-title":"Norepinephrine acts as D1-dopaminergic agonist in the embryonic avian retina: late expression of beta1-adrenergic receptor shifts norepinephrine specificity in the adult tissue","volume":"50","author":"Kubrusly","year":"2007","journal-title":"Neurochem Int"},{"issue":"2","key":"10.1016\/j.neuroscience.2008.12.026_bib14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1471-4159.1997.68020804.x","article-title":"Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor","volume":"68","author":"Lanau","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2008.12.026_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00702-007-0852-z","article-title":"Pharmacological treatment of Parkinson's disease: life beyond dopamine D2\/D3 receptors?","volume":"1153","author":"Linazasoro","year":"2008","journal-title":"J Neural Transm"},{"issue":"1","key":"10.1016\/j.neuroscience.2008.12.026_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.neuroscience.2008.12.026_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0306-4522(93)90116-W","article-title":"Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain","volume":"57","author":"McCune","year":"1993","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuroscience.2008.12.026_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2007.04456.x","article-title":"Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease","volume":"101","author":"Mela","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2008.12.026_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-211-73574-9_14","article-title":"Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects","volume":"72","author":"Nagatsu","year":"2007","journal-title":"J Neural Transm Suppl"},{"issue":"2\u20133","key":"10.1016\/j.neuroscience.2008.12.026_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0014-2999(96)00985-5","article-title":"Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors","volume":"319","author":"Newman-Tancredi","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.neuroscience.2008.12.026_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-6147(96)10022-5","article-title":"The distribution and significance of CNS adrenoceptors examined with in situ hybridization","volume":"17","author":"Nicholas","year":"1996","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.neuroscience.2008.12.026_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0026-895X(25)13494-9","article-title":"Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum","volume":"28","author":"Onali","year":"1985","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2008.12.026_bib23","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1998"},{"issue":"4","key":"10.1016\/j.neuroscience.2008.12.026_bib24","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mds.1143","article-title":"Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease","volume":"16","author":"Rascol","year":"2001","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neuroscience.2008.12.026_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcp.2007.01.036","article-title":"Norepinephrine: The redheaded stepchild of Parkinson's disease","volume":"74","author":"Rommelfanger","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"10.1016\/j.neuroscience.2008.12.026_bib26","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/mds.10464","article-title":"Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"18","author":"Savola","year":"2003","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.neuroscience.2008.12.026_bib27","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/jnnp.2004.035980","article-title":"Present and future drug treatment for Parkinson's disease","volume":"76","author":"Schapira","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"16","key":"10.1016\/j.neuroscience.2008.12.026_bib28","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1097\/00001756-199711100-00001","article-title":"Regional distribution of dopamine D4 receptors in rat forebrain","volume":"8","author":"Tarazi","year":"1997","journal-title":"Neuroreport"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2008.12.026_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0169-328X(03)00026-3","article-title":"The alpha2C-adrenoceptor modulates GABA release in mouse striatum","volume":"112","author":"Zhang","year":"2003","journal-title":"Brain Res Mol Brain Res"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645220801840X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645220801840X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T11:23:44Z","timestamp":1738841024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645220801840X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S030645220801840X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2008.12.026","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}